Robot Companions and Depression: Evidence, Safe Use and Limits

Evidence-based guide · Reviewed July 13, 2026

A robot can prompt the next step. It cannot treat depression alone.

Robot companions may make a routine easier to start, offer a pleasant activity or prompt contact with another person. Those are plausible support roles—not proof that a device diagnoses, treats or prevents depression. This guide separates the evidence from the sales language and shows how to test a robot without displacing human care.

Evidence is indirectMost trials involve older adults or dementia, not major depressive disorder
Human care stays centralPsychotherapy and medication have established clinical roles
One goal per trialMeasure a specific routine or connection outcome, not “companionship”

Depression is more than a difficult day

Depression can involve persistent low or irritable mood, loss of interest or pleasure, fatigue, sleep or appetite changes, poor concentration, guilt, hopelessness and thoughts of death. The World Health Organization distinguishes a depressive episode from ordinary mood changes by its duration, pattern and effect on daily functioning. The diagnosis is not something a consumer robot can make from a voice, face, activity log or questionnaire.

Professional assessment matters because similar symptoms can appear with grief, chronic pain, thyroid and other medical conditions, medication effects, substance use, trauma, dementia and bipolar disorder. A history of unusually high energy, much less need for sleep, racing thoughts or risky behavior can point toward mania or hypomania and changes the clinical approach. An automated “mood score” cannot safely resolve those differences.

01

Symptoms

Notice duration, severity and loss of function—not just whether someone sounds sad in one conversation.

02

Context

Health, medication, sleep, grief, safety, substance use and prior episodes belong in the assessment.

03

Preferences

Treatment decisions should be shared, informed and compatible with the person’s needs and values.

04

Follow-up

Symptoms and side effects need human review; a device dashboard is not clinical monitoring by itself.

Promising activity, uncertain antidepressant effect

The central limitation is population mismatch. Most social-robot studies measure short-term outcomes in care homes, older adults with cognitive impairment or people living with dementia. Those findings cannot simply be transferred to a younger adult with major depressive disorder, postpartum depression, bipolar depression or severe recurrent depression.

Recent positive signal

Small effect in cognitive impairment

A 2026 meta-analysis of eight randomized trials and 514 older adults with cognitive impairment found a small reduction in depressive symptoms. The benefit appeared in dementia, not mild cognitive impairment, and in interventions of six weeks or less, not longer ones.

Read the PubMed abstract

Conflicting review

No significant depression effect

A 2025 meta-analysis of 15 randomized dementia studies found improvements in agitation and anxiety but no significant effect on depression, cognition or quality of life. Different robots, controls, settings and schedules make pooled results unstable.

Read the PubMed abstract

Broader caution

Benefit remains unclear

A review of 66 dementia studies found robots generally feasible and acceptable, yet its meta-analysis found no clear benefit for depression or other clinical outcomes. Acceptability and novelty are not the same as treatment effectiveness.

Read the PubMed abstract

Question What is known What is not established Responsible conclusion
Can a robotic pet create a pleasant moment? Short sessions can be engaging and acceptable for some older adults, including people with dementia. Whether the response persists after novelty fades or improves broader functioning. Plausible supportTest the activity, preference and burden.
Can it reduce depressive symptoms? Some pooled analyses report small short-term changes in narrow older populations. A consistent effect across reviews, age groups, diagnoses and longer follow-up. Mixed evidenceDo not promise a health outcome.
Can it treat major depressive disorder? No robust body of trials establishes consumer robot companions as a treatment for major depression. Comparative effectiveness, dose, durability, adverse effects and who benefits. Not establishedNever replace clinical care.
Can it prevent suicide or detect crisis? Consumer devices may offer generic prompts or contact shortcuts. Reliable risk detection, emergency response or continuous safety coverage. Do not rely on itUse a human safety plan and crisis services.

Why reviews disagree

Robot studies often combine dissimilar products, from a seal-shaped tactile device to a conversational screen. Trials may compare usual care, an activity, a live animal or another technology; measure different scales; use small samples; and last only a few weeks. Staff attention and novelty can also influence results. A statistically significant average change does not prove that the robot caused meaningful recovery for an individual.

Six support roles worth testing

A useful robot does not need to imitate a therapist. It needs to make one agreed action easier, more pleasant or more consistent while preserving the person’s autonomy. Each role below should connect to a human-authored plan and have a manual alternative.

Routine cue

Begin one small action

Prompt opening curtains, drinking water, preparing breakfast or starting a hygiene routine at a chosen time.

MeasureWas the action easier to begin?

Connection

Reach a real person

Offer a one-tap call or a prompt to message a trusted contact without pretending that machine conversation equals reciprocal support.

MeasureDid meaningful human contact increase?

Shared activity

Create a reason to join

Use music, photos, trivia or gentle play with a family member, peer or care worker instead of isolating the user with the device.

MeasureDid participation and enjoyment improve?

Pleasant event

Add a low-demand moment

Touch, movement or a familiar sound may offer brief sensory engagement when the person voluntarily enjoys it.

MeasureCalmer or more engaged afterward?

Appointment cue

Support an existing plan

Remind the user about therapy, a support group or a medical appointment and provide the correct contact shortcut.

MeasureFewer missed appointments?

Reflection

Prepare for human care

Store a simple, user-controlled note about sleep, energy or questions to discuss with a clinician—without automated diagnosis.

MeasureWas the clinical conversation clearer?

A robot may

  • cue a user-selected action;
  • play a familiar activity;
  • open a contact or appointment;
  • work as a shared social object;
  • repeat neutral instructions.
A robot must not be trusted to

  • diagnose depression or bipolar disorder;
  • assess suicide risk;
  • change therapy or medication;
  • promise confidentiality it cannot provide;
  • replace family, clinicians or crisis services.

Three products illustrate three different support models

These are examples, not a depression ranking. None has established itself as a treatment for major depressive disorder. Availability, pricing and services change, so confirm official terms before buying and prefer a trial with an easy exit.

Conversation and routines

ElliQ

ElliQ is a stationary older-adult engagement service with conversation, activities and family features. Its proactive format may help initiate a routine, but it is leased through a paid membership and is not an emergency monitoring service.

  • Test real hearing, speech and internet conditions.
  • Set one family-contact or routine goal.
  • Understand contract, return and data terms.

Official membership information

Touch and movement

LOVOT

LOVOT emphasizes warmth, gaze, movement and being held rather than practical assistance. The concept may suit someone who enjoys tactile interaction, but official sales and service are Japan-focused and total ownership cost is high.

  • Experience it physically before purchase.
  • Check noise, charging, floors and maintenance.
  • Treat comfort claims as manufacturer claims.

Official LOVOT site

Supervised therapeutic activity

PARO

PARO is a seal-shaped therapeutic robot used mainly in care settings and studied largely with older adults and dementia. It can be an activity facilitated by staff; that does not make it an approved standalone treatment for depression.

  • Define who facilitates and cleans it.
  • Compare with music, pets and human activities.
  • Observe consent, distress and withdrawal.

Official PARO site

Run a four-week, one-goal trial

Depression can make complex setup and performance targets feel punishing. Keep the experiment small. The purpose is not to prove that the user can “try harder”; it is to learn whether the device reduces friction without creating pressure, dependency or privacy costs.

  1. Week 0
    Choose one functional goal.

    Examples: place two calls per week, begin breakfast before noon on four days, or attend one scheduled group. The user chooses the goal; a clinician or caregiver can help make it realistic.

  2. Week 1
    Record the baseline without the robot.

    Track completion, distress, human assistance and obstacles. Do not collect more intimate data than the decision requires.

  3. Week 2
    Add the smallest robot feature.

    Use one prompt, shortcut or shared activity. Disable unrelated notifications, cameras, recognition and conversation histories.

  4. Week 3
    Check the human connection.

    Ask whether the feature leads outward to people and care, or whether it is becoming an excuse for others to visit and call less.

  5. Week 4
    Compare and decide.

    Continue only if the selected outcome improved, burden stayed acceptable and the user still freely wants the device. Adapt or return it otherwise.

Outcome

Did the target happen?

Use a count or yes/no record tied to the single goal, not a vague happiness score.

Effort

Was it easier?

Record setup, troubleshooting, prompting and caregiver time as costs, not invisible labor.

Experience

Was it welcome?

Notice annoyance, guilt, pressure, sensory discomfort, surveillance concerns and enjoyment.

Generalization

Did life expand?

Look for more human contact or independent action, not only more minutes spent with the robot.

Continue

The specific outcome improved, the person wants the device and human support stayed equal or increased.

Adapt

There is some value, but prompts, timing, sensory load, privacy settings or caregiver expectations need revision.

Stop

Symptoms worsen, the device creates guilt or distress, human contact falls, privacy is unacceptable or the goal does not improve.

Six risks to discuss before setup

False empathy

Fluent language feels reciprocal

A system can produce warm sentences without understanding, duty of care or a confidential therapeutic relationship. Label it honestly.

Displacement

People may step back

A family or facility may unconsciously treat the device as delivered companionship. Protect scheduled calls, visits and professional care.

Dependency

The service can disappear

Plans, servers and companies change. Maintain non-robot routines and prepare a considerate transition if the product fails.

Privacy

Low mood invites intimate disclosure

Voice, video, faces, health notes and home patterns may enter vendor systems. Minimize collection and know deletion options.

Bad advice

Generated answers can be wrong

Do not ask a consumer companion for diagnosis, medication guidance, crisis judgment or treatment decisions.

Performance pressure

Prompts can become criticism

Repeated streaks, scores or cheerful reminders may intensify guilt. Make every cue optional, easy to silence and free of punishment.

Minimum data

  • No always-on camera unless essential.
  • No emotion recognition for clinical decisions.
  • No unnecessary voice-history retention.
  • No shared account with unclear access.

Minimum dependence

  • A manual route for every important action.
  • Human contact not contingent on the robot.
  • Written return and cancellation dates.
  • A plan for outage, repair and shutdown.

When to seek professional or urgent help

Contact a health professional when symptoms persist, interfere with work, school, self-care or relationships, recur, or cause concern. A primary-care clinician can assess physical contributors and connect the person with mental-health care; a licensed mental-health professional can evaluate and treat depression. If a current treatment is not helping or creates side effects, tell the treating professional rather than quietly substituting a robot.

Arrange an assessment

Persistent or impairing symptoms

Low mood, loss of interest, sleep or appetite change, severe fatigue, concentration problems, guilt or hopelessness deserve evaluation when they persist or disrupt life.

Seek prompt clinical advice

Possible mania or psychosis

Very little need for sleep with high energy, racing thoughts, risky behavior, hallucinations, severe confusion or loss of reality require timely professional assessment.

Use urgent human support

Self-harm or immediate danger

Contact local emergency or crisis services and a trusted person. In the US and territories, call or text 988; call 911 for a life-threatening emergency.

24-point depression support checklist

Clinical foundation
Purpose
Data and safety
Exit

Robot companions and depression FAQ

Can robot companions cure depression?

No. Consumer robot companions are not established cures or standalone treatments for depression. Evidence-based care can include psychotherapy, medication or both, selected with a qualified professional according to symptoms, severity, history and preference.

Can a robot help someone feel less alone?

It may create a pleasant interaction or prompt contact, and some people value that experience. It cannot provide mutual human attachment. Measure whether it increases calls, visits and shared activity rather than only time spent with the device.

What is the best robot for depression?

There is no evidence-based best robot for depression. Choose only after defining a narrow task: a routine cue, human-contact shortcut or supervised activity. Compare the product with a simpler reminder, phone, music player or scheduled human support.

Is PARO approved to treat depression?

PARO is marketed as a therapeutic robot and has medical-device regulatory history, but that does not establish it as an approved standalone treatment for major depressive disorder. Research is concentrated in older-adult and dementia care, with mixed depression findings.

Can a robot detect suicidal thoughts?

Do not rely on a consumer robot to detect or respond to suicide risk. If there is immediate danger or possible self-harm, contact local emergency or crisis services and a trusted person. In the US and territories, call or text 988.

Should a robot track mood every day?

Only if the person and clinician find a simple record useful and privacy is acceptable. Frequent scoring can increase rumination or create false certainty. A brief user-controlled note is safer than opaque emotion recognition.

Can a robot replace therapy when therapy is unavailable?

No. Access barriers are real, but a companion robot does not become a licensed therapist because care is difficult to obtain. Ask primary care, local mental-health services, community organizations, support lines or telehealth providers about available human options.

Judge the robot by the door it opens to human life

A robot companion may earn a supporting role when it helps one chosen routine begin, makes a shared activity inviting or lowers the friction of contacting another person. The evidence does not support presenting it as a treatment, diagnosis, therapist or crisis monitor. Keep the trial reversible, the data minimal and professional and social care firmly in place.

Sources and review method

Clinical framing was checked against the World Health Organization depression fact sheet, National Institute of Mental Health depression guide and NICE guideline NG222. Robot evidence was interpreted from systematic reviews and meta-analyses indexed by PubMed, including 2026 cognitive-impairment trials, 2025 dementia trials, a 66-study dementia review and a review finding no significant depression effect. We prioritize diagnosis match, controlled evidence, functional outcomes, follow-up and harms over testimonials or manufacturer wellness claims.

William Reeves, editor of Robot Companion AI

About the editor

William Reeves

Editor of RobotCompanion.online

William Reeves is the editor of RobotCompanion.online, where he explores the latest developments in AI companions, social robots, and human-technology relationships. He focuses on making complex ideas easy to understand while providing practical, balanced, and well-researched information for readers interested in the future of personal robotics.